This online curriculum addresses the unmet needs in personalised management of Prostate Cancer patients with history and risk of CVD events and is a mix of live webinars, case discussions, Q&A and discussions by key opinion leaders in prostate cancer. The programme is developed by The Canadian Urological Association, the International Cardio-Oncology Society together with the European Association of Urology.
The curriculum is divided in a series of educational online modules, each one consisting of pre-recorded sessions and a live webinar. Participants are recommended to watch the pre-recorded lectures as a preparation for the live webinar. Attending the live webinar is free (registration required) and participants joining live will receive accreditation points.
Module 1: CVD in prostate cancer patients – Increased risks & comorbidities
Pre-recorded lectures
Live webinar
Module 2: Debate – How to manage CVD risk in PCa patients during COVID 19
Live webinar
Module 3: Advances in safety in the treatment of PCa
Pre-recorded lectures
Live webinar
Module 4: Future directions in PCa management
Live webinar
This educational activity has been funded by Ferring Pharmaceuticals. The educational programme of this online activity has been a collaboration with Ferring, but independently developed and approved by the Canadian Urological Association, the International Cardio-Oncology Society together with the European Association of Urology.